MASHINIi

ECKERT+ZIEGLER.

EUZ.XETRA | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Eckert & Ziegler Strahlen- und Medizintechnik AG is a globally operating group of companies specializing in isotope technology for medical, scientific and industrial applications. The company operates through three segments: Isotope Products, Isotope Technologies, and Radiopharma. The Isotope Produc...Show More

Ethical Profile

Mixed.

Eckert & Ziegler (EUZ.XETRA) aids 'Better Health for All' through radiopharmaceuticals for cancer diagnosis and therapy, maintaining a strong safety record. Yet, its ethical profile is mixed. The company has experienced cyberattacks and a data breach; reports suggest server logs were stored unencrypted for 7 days. Employee reviews on platforms like Glassdoor cite concerns over management, morale, and career advancement, with compensation rated 2.5/5, despite 60% of employees reportedly earning living wages. Its core business with radioactive materials also inherently challenges 'Planet-Friendly Business' and 'Zero Waste' goals, though recycling services are offered.

Value Scores

Better Health for All10
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products-30
-100100

Better Health for All

10

The company's core business is the manufacturing and supply of radiopharmaceuticals and medical devices for cancer diagnosis and targeted therapies. This includes alpha-emitting radiopharmaceuticals for Targeted Alpha Therapy (TAT) using Actinium-225 and Lead-212

1
, as well as Lutetium-177 for solid tumors
2
, small cell lung cancer, and Merkel Cell Carcinoma
3
. These products are supplied for clinical trials (phases I, II, and III) and commercial use
4
, indicating a significant health-positive impact that is central to the company's business strategy. The company's products do not have addiction potential and are not food or nutritional products.
5

Fair Money & Economic Opportunity

0

Eckert & Ziegler specializes in isotope technology for medical, scientific, and industrial applications. Its core business does not involve lending, insuring, moving, or storing money for consumers. Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility for financial products, fair lending compliance, wealth building outcomes, profit reinvestment in community finance, financial literacy initiatives, debt burden ratio, geographic inclusion for banking, and product simplicity for financial products, are not applicable to the company's operations. The provided articles contain no evidence relevant to these financial metrics.

1

Fair Pay & Worker Respect

0

The company's overall employee rating from Glassdoor reviews is 3.4 out of 5 stars

1
, which translates to an engagement score of 68%. This score indicates a healthy workplace culture.

Fair Trade & Ethical Sourcing

0

No evidence available to assess ECKERT+ZIEGLER on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No evidence available to assess ECKERT+ZIEGLER on Honest & Fair Business.

Kind to Animals

0

No specific, concrete data points were found in the provided articles regarding EUZ.XETRA's practices related to animal welfare, animal testing, ethical sourcing of animal-derived ingredients, or wildlife conservation. The articles focus on the company's radiopharmaceutical manufacturing and medical device services, with no information on cruelty-free certifications, alternative testing methods, humane certifications for operations, or investment in animal-free technologies.

1

No War, No Weapons

0

No specific, quantifiable evidence was found in the provided articles to assess EUZ.XETRA against any of the 'No War, No Weapons' KPIs. The articles describe the company's focus on isotope technology for medical, scientific, and industrial applications

1
, and discuss general sustainability without providing specific metrics related to arms, defense, conflict, or peacebuilding initiatives
2
.

Planet-Friendly Business

0

No evidence available to assess ECKERT+ZIEGLER on Planet-Friendly Business.

Respect for Cultures & Communities

0

No specific, concrete data points relevant to EUZ.XETRA's performance on any of the 'Respect for Cultures & Communities' KPIs were found in the provided articles. The articles either explicitly stated no data pertaining to the company

1
, discussed general industry practices or guidelines
2
, or focused on job postings and employee reviews without addressing community engagement or cultural respect metrics
3
.

Safe & Smart Tech

0

The company uses SSL protocol for data transfer, though server logs are stored unencrypted for 7 days before being encrypted and stored indefinitely.

1
It outlines user rights to access, correct, erase, and limit data processing, as defined by GDPR.
2
The company also notes compliance with GDPR and the German Telemedia Act (TMG).
3

Zero Waste & Sustainable Products

-30

Eckert & Ziegler has maintained a record of zero reportable accidents, zero environmental incidents, and zero regulatory improvement or enforcement notices related to waste disposal over 25+ years of operation.

1
The company implements waste reduction initiatives, including a system for returning and recycling spent radioactive sources, which are fed back into the production cycle.
2
Additionally, it operates in-house facilities for recycling various radioactive materials in Germany, the Czech Republic, and the USA, and offers waste treatment services such as volume reduction.
3

Own ECKERT+ZIEGLER?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.